Graham Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,931	Closed	-$321K	–	1250
2025 Q3	$321K	Sell	5,931 -71,977	-92%	-$4.12M	0.01%	829
2025 Q2	$4.28M	Buy	77,908 +58,891	+310%	+$3.47M	0.13%	172
2025 Q1	$1.34M	Buy	+19,017	New	+$1.28M	0.04%	463
2024 Q4	–	Sell	-13,038	Closed	-$916K	–	1242
2024 Q3	$916K	Buy	13,038 +5,709	+78%	+$477K	0.03%	488
2024 Q2	$603K	Sell	7,329 -14,453	-66%	-$1.2M	0.02%	528
2024 Q1	$1.9M	Buy	+21,782	New	+$1.95M	0.05%	263
2023 Q3	–	Sell	-40,223	Closed	-$3.49M	–	1026
2023 Q2	$3.49M	Buy	+40,223	New	+$3.79M	0.12%	136
2022 Q4	–	Sell	-31,003	Closed	-$2.63M	–	1062
2022 Q3	$2.63M	Buy	31,003 +26,503	+589%	+$2.36M	0.11%	152
2022 Q2	$372K	Sell	4,500 -12,977	-74%	-$1.03M	0.02%	760
2022 Q1	$1.35M	Buy	17,477 +14,056	+411%	+$1.18M	0.06%	209
2021 Q4	$302K	Buy	+3,421	New	+$282K	0.02%	322